These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 22450386)
1. Visualization of endolymphatic hydrops in Ménière's disease after single-dose intravenous gadolinium-based contrast medium: timing of optimal enhancement. Naganawa S; Yamazaki M; Kawai H; Bokura K; Sone M; Nakashima T Magn Reson Med Sci; 2012; 11(1):43-51. PubMed ID: 22450386 [TBL] [Abstract][Full Text] [Related]
2. Visualization of endolymphatic hydrops in Ménière's disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Naganawa S; Yamazaki M; Kawai H; Bokura K; Sone M; Nakashima T Magn Reson Med Sci; 2010; 9(4):237-42. PubMed ID: 21187694 [TBL] [Abstract][Full Text] [Related]
3. Contrast enhancement of the anterior eye segment and subarachnoid space: detection in the normal state by heavily T2-weighted 3D FLAIR. Naganawa S; Yamazaki M; Kawai H; Sone M; Nakashima T Magn Reson Med Sci; 2011; 10(3):193-9. PubMed ID: 21960002 [TBL] [Abstract][Full Text] [Related]
4. Correlation of endolymphatic hydrops and perilymphatic enhancement with the clinical features of Ménière's disease. Li J; Jin X; Kong X; Hu N; Li X; Wang L; Liu M; Li C; Liu Y; Sun L; Gong R Eur Radiol; 2024 Sep; 34(9):6036-6046. PubMed ID: 38308680 [TBL] [Abstract][Full Text] [Related]
5. The correlation between symptoms of definite Meniere's disease and endolymphatic hydrops visualized by magnetic resonance imaging. Wu Q; Dai C; Zhao M; Sha Y Laryngoscope; 2016 Apr; 126(4):974-9. PubMed ID: 26333096 [TBL] [Abstract][Full Text] [Related]
6. Relationship between Contrast Enhancement of the Perivascular Space in the Basal Ganglia and Endolymphatic Volume Ratio. Ohashi T; Naganawa S; Katagiri T; Kuno K Magn Reson Med Sci; 2018 Jan; 17(1):67-72. PubMed ID: 28592709 [TBL] [Abstract][Full Text] [Related]
7. Time course for measuring endolymphatic size in healthy volunteers following intravenous administration of gadoteridol. Naganawa S; Suzuki K; Yamazaki M; Sakurai Y; Ikeda M Magn Reson Med Sci; 2014; 13(2):73-80. PubMed ID: 24769637 [TBL] [Abstract][Full Text] [Related]
8. Semi-quantification of endolymphatic size on MR imaging after intravenous injection of single-dose gadodiamide: comparison between two types of processing strategies. Naganawa S; Suzuki K; Nakamichi R; Bokura K; Yoshida T; Sone M; Homann G; Nakashima T; Ikeda M Magn Reson Med Sci; 2013 Dec; 12(4):261-9. PubMed ID: 24172793 [TBL] [Abstract][Full Text] [Related]
9. Three-dimensional visualization of endolymphatic hydrops after intravenous administration of single-dose gadodiamide. Naganawa S; Yamazaki M; Kawai H; Bokura K; Sone M; Nakashima T Magn Reson Med Sci; 2013; 12(2):147-51. PubMed ID: 23666157 [TBL] [Abstract][Full Text] [Related]
10. [Clinical features and imaging characteristics of Meniere's disease verified by intravenous gadolinium contrast-enhanced magnetic resonance imaging]. Shi SM; Sun WF; Wang WQ Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1218-1222. PubMed ID: 29747307 [No Abstract] [Full Text] [Related]
11. Visualization of white matter tracts using a non-diffusion weighted magnetic resonance imaging method: does intravenous gadolinium injection four hours prior to the examination affect the visualization of white matter tracts? Yamazaki M; Naganawa S; Kawai H; Ikeda M; Bokura K; Isoda H; Nakashima T PLoS One; 2014; 9(3):e91860. PubMed ID: 24622649 [TBL] [Abstract][Full Text] [Related]
12. [Visualization of endolymphatic hydrops in 3D-FLAIR MRI after intratympanic Gd-DTPA administration in Meniere's disease patients]. Zhang DG; Shi HL; Fan ZM; Wang GB; Han YC; Li YW; Wang HB Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Aug; 48(8):628-33. PubMed ID: 24195817 [TBL] [Abstract][Full Text] [Related]
13. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Naganawa S; Kawai H; Sone M; Nakashima T Magn Reson Med Sci; 2010; 9(2):73-80. PubMed ID: 20585197 [TBL] [Abstract][Full Text] [Related]
14. Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide. Naganawa S; Kawai H; Taoka T; Suzuki K; Iwano S; Satake H; Sone M; Ikeda M Magn Reson Med Sci; 2016 Jul; 15(3):308-15. PubMed ID: 26841857 [TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging of Ménière's Disease After Intravenous Administration of Gadolinium. Shi S; Guo P; Wang W Ann Otol Rhinol Laryngol; 2018 Nov; 127(11):777-782. PubMed ID: 30156867 [TBL] [Abstract][Full Text] [Related]
16. Delayed intravenous contrast-enhanced 3D FLAIR MRI in Meniere's disease: correlation of quantitative measures of endolymphatic hydrops with hearing. Sepahdari AR; Ishiyama G; Vorasubin N; Peng KA; Linetsky M; Ishiyama A Clin Imaging; 2015; 39(1):26-31. PubMed ID: 25457542 [TBL] [Abstract][Full Text] [Related]
17. Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents. Suzuki H; Teranishi M; Sone M; Yamazaki M; Naganawa S; Nakashima T Acta Otolaryngol; 2011 Oct; 131(10):1025-31. PubMed ID: 21732744 [TBL] [Abstract][Full Text] [Related]
18. Endolymphatic hydrops in Meniere's disease detected by MRI after intratympanic administration of gadolinium: comparison with sudden deafness. Horii A; Osaki Y; Kitahara T; Imai T; Uno A; Nishiike S; Fujita N; Inohara H Acta Otolaryngol; 2011 Jun; 131(6):602-9. PubMed ID: 21344957 [TBL] [Abstract][Full Text] [Related]
19. Imaging of endolymphatic and perilymphatic fluid after intravenous administration of single-dose gadodiamide. Naganawa S; Yamazaki M; Kawai H; Bokura K; Sone M; Nakashima T Magn Reson Med Sci; 2012; 11(2):145-50. PubMed ID: 22790302 [TBL] [Abstract][Full Text] [Related]
20. Visualization of endolymphatic hydrops in Ménière's disease after intravenous administration of single-dose gadodiamide at 1.5T. Naganawa S; Yamazaki M; Kawai H; Bokura K; Sone M; Nakashima T Magn Reson Med Sci; 2013; 12(2):137-9. PubMed ID: 23666156 [No Abstract] [Full Text] [Related] [Next] [New Search]